Myositis-specific and myositis-associated autoantibodies in dermatomyositis and polymyositis

Clinical Application of Immunology

Volumn 5, Issue 1, 2006, Pages 533-537

  Dourmishev, Lyubomir ^a   Wollina, Uwe ^b   Hipler, Ute Christina ^c   Peytcheva, Veneta ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Autoantibodies; Dermatomyositis; Polymyositis

Indexed keywords

52KD RO ANTIBODY; 60KD RO ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; JO 1 ANTIBODY; KU ANTIBODY; LA ANTIBODY; POLYMYOSITIS SCL ANTIBODY; PROTEIN ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SINGLE STRANDED DNA; SM ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; POLYMYOSITIS; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

EID: 34247231566     PISSN: 13120832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dourmishev LA. Dermatomyositis associated with malignancy. 12 case reports. Adv Exp Med Biol 1999; 455: 193-9.
2. Blaszczyk M, Jablonska S, Szymanska-Jagiello W, Jarzabek-Chorzelska M. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 1991; 8: 1-8.
3. Love LA, Leff RL, Fraser DD. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991; 70: 360-74.
4. Sherer Y, Livneh A, Levy Y. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome. Lupus 2000; 9: 42-6.
5. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991; 24: 959-66.
6. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993; 100: 116S-123S.
7. Tanimoto K, Nakano K, Kano S. Criteria for polymyositis and dermatomyositis. J Rheumatol 1995; 22: 668-74.
8. Ghirardello A, Doria A, Zampieri S. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 975-981.
9. Reichlin M, Arnett FC. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984; 27: 1150-6.
10. Bayer PM, Bauerfeind S, Bienvenu J. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun, 1999; 13: 89-93.
11. Knopf B, Wollina U, Feldrappe S. Zum Einfluß der Kultivierungsdauer von Crithidia luciliae auf die Bindung von Antikorpern gegen ds-DNA. Z. Med. Laboratoriumsdiagnostik 1987; 28: 272-274.
12. Wollina U. Neuere Aspekte zu ausgewählten Autoantikörpern bei Patienten mit systemischem Lupus erythematodes. I. Mitteilung: DNS-bindende Autoantikörper. Allergie und Immunologic, 1983; 29: 127-134.
13. Wollina U. Neuere Aspekte zu ausgewahlten Autoantikörpern bei Patienten mit systemischem Lupus erythematodes. II. Mitteilung: Antikörper gegen Histon, Sm, Ro und La. Allergie und Immunologie 1983; 29: 135-144.
14. Wollina U. Neuere Aspekte zu ausgewahlten Autoantikörpern bei Patienten mit systemischem Lupus erythematodes. III. Mitteilung.: RNS-bindende Autoantikörper, RNP. Allergie und Immunologie 1983; 29: 191-199.
15. Miller FW. Myositis - specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA 1993; 15: 1846-9.
16. Gonzalez C, Garcia-Berrocal B, Perez M et al. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients. Clin Chim Acta 2005 12; (Epub ahead of print).
17. Nishikai M, Ohya K, Kosaka M. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 1998; 37: 357-61.
18. Roux S, Seelig HP, Meyer O. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis. J Rheumatol 1998; 25: 395-6.
19. Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T: Immunoserological aspects of idiopathic inflammatory muscle disease. Wien Klin Wochenschr 2000; 112: 722-7.
20. Targoff IN: Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol, 100: 116S-123S, 1993.
21. Vazquez-Abad D, Rothfield NF. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 1996; 39: 292-6.
22. Targoff IN. Update on myositis-specific and myositis associated autoantibodies. Curr Opin Rheumatol 2000; 12: 475-81.
23. Arnett FC, Targoff IN, Mimori T et al. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum, 1996; 39: 1507-18.
24. Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004;16:692-9.
25. Frank MB, Mc Cubbin V, Trieu E et al. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun, 1999; 12: 137-42.
26. Rutjes SA, Vree Egberts WT, Jongen P et al.: Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32-40.
27. Venables PJ. Antibodies to Jo-1 and Ro-52: why do they go together? Clin Exp Immunol 1997; 109: 403-5.
28. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998; 95: 279-89.